Systemic responses of mice to dextran sulfate sodium-induced acute ulcerative colitis using 1H NMR spectroscopy

Journal of Proteome Research

Volumn 12, Issue 6, 2013, Pages 2958-2966

  Dong, Fangcong ^a,b   Zhang, Lulu ^a,b   Hao, Fuhua ^a   Tang, Huiru ^a   Wang, Yulan ^a,c  

^a Wuhan National Laboratory for Optoelectronics   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

dextran sulfate sodium; inflammatory bowel diseases; metabonomics; mice; nuclear magnetic resonance spectroscopy; ulcerative colitis

Indexed keywords

ACETIC ACID; ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; AMINO ACID; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; DEXTRAN SULFATE; FUMARIC ACID; GLUCOSE; GLUTAMINE; GLUTATHIONE DISULFIDE; GLYCEROL; GLYCEROPHOSPHORYLCHOLINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LACTATE DEHYDROGENASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYSINE; NUCLEIC ACID BASE; NUCLEOSIDE; NUCLEOTIDE; OMEGA 3 FATTY ACID; PHENYLALANINE; PHOSPHORYLCHOLINE; TAURINE; TRIACYLGLYCEROL; URACIL; URIC ACID; URIDINE; VALINE;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CITRIC ACID CYCLE; COLON INJURY; CONTROLLED STUDY; ENERGY METABOLISM; FOOD INTAKE; HISTOPATHOLOGY; INTESTINE FLORA; LIPID METABOLISM; LIVER INJURY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; ULCERATIVE COLITIS; URINALYSIS; WEIGHT GAIN;

MUS;

EID: 84879359598     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr4002383     Document Type: Article

References (57)

1. Loftus, E. V. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences Gastroenterology 2004, 126 (6) 1504-1517
2. Hanauer, S. B. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities Inflamm. Bowel Dis. 2006, 12, S3-S9
3. Xavier, R. J.; Podolsky, D. K. Unravelling the pathogenesis of inflammatory bowel disease Nature 2007, 448 (7152) 427-434
4. Hugot, J. P.; Chamaillard, M.; Zouali, H.; Lesage, S.; Cezard, J. P.; Belaiche, J.; Almer, S.; Tysk, C.; O'Morain, C. A.; Gassull, M.; Binder, V.; Finkel, Y.; Cortot, A.; Modigliani, R.; Laurent-Puig, P.; Gower-Rousseau, C.; Macry, J.; Colombel, J. F.; Sahbatou, M.; Thomas, G. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease Nature 2001, 411 (6837) 599-603
5. Ogura, Y.; Bonen, D. K.; Inohara, N.; Nicolae, D. L.; Chen, F. F.; Ramos, R.; Britton, H.; Moran, T.; Karaliuskas, R.; Duerr, R. H.; Achkar, J. P.; Brant, S. R.; Bayless, T. M.; Kirschner, B. S.; Hanauer, S. B.; Nunez, G.; Cho, J. H. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease Nature 2001, 411 (6837) 603-606
6. Stoll, M.; Corneliussen, B.; Costello, C. M.; Waetzig, G. H.; Mellgard, B.; Koch, W. A.; Rosenstiel, P.; Albrecht, M.; Croucher, P. J. P.; Seegert, D.; Nikolaus, S.; Hampe, J.; Lengauer, T.; Pierrou, S.; Foelsch, U. R.; Mathew, C. G.; Lagerstrom-Fermer, M.; Schreiber, S. Genetic variation in DLG5 is associated with inflammatory bowel disease Nat. Genet. 2004, 36 (5) 476-480
7. Brant, S. R.; Panhuysen, C. I. M.; Nicolae, D.; Reddy, D. M.; Bonen, D. K.; Karaliukas, R.; Zhang, L. L.; Swanson, E.; Datta, L. W.; Moran, T.; Ravenhill, G.; Duerr, R. H.; Achkar, J. P.; Karban, A. S.; Cho, J. H. MDR1 Ala893 polymorphism is associated with inflammatory bowel disease Am. J. Hum. Genet. 2003, 73 (6) 1282-1292
8. Ho, G. T.; Nimmo, E. R.; Tenesa, A.; Fennell, J.; Drummond, H.; Mowat, C.; Arnott, I. D.; Satsangi, J. Allelic variations of the multidrug resistance gene determine susceptibility and disease behavior in ulcerative colitis Gastroenterology 2005, 128 (2) 288-296
9. Dubuquoy, L.; Jansson, E. A.; Deeb, S.; Rakotobe, S.; Karoui, M.; Colombel, J. F.; Auwerx, J.; Pettersson, S.; Desreumaux, P. Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis Gastroenterology 2003, 124 (5) 1265-1276
10. Vanderploeg, R.; Panaccione, R.; Ghosh, S.; Rioux, K. Influences of intestinal bacteria in human inflammatory bowel disease Infect. Dis. Clin. North Am. 2010, 24 (4) 977-993
11. Nicholson, J. K.; Lindon, J. C.; Holmes, E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data Xenobiotica 1999, 29 (11) 1181-1189
12. Tang, H. R.; Wang, Y. L. Metabonomics: a revolution in progress Prog. Biochem. Biophys. 2006, 33 (5) 401-417
13. Bjerrum, J. T.; Nielsen, O. H.; Wang, Y. L.; Olsen, J. Technology insight: metabonomics in gastroenterology-basic principles and potential clinical applications Nat. Clin. Pract. Gastroenterol. Hepatol. 2008, 5 (6) 332-343
14. 1H NMR spectroscopy-based metabonomic study J. Proteome Res. 2012, 11 (10) 4992-5004
15. Williams, H. R. T.; Cox, I. J.; Walker, D. G.; North, B. V.; Patel, V. M.; Marshall, S. E.; Jewell, D. P.; Ghosh, S.; Thomas, H. J. W.; Teare, J. P.; Jakobovits, S.; Zeki, S.; Welsh, K. I.; Taylor-Robinson, S. D.; Orchard, T. R. Characterization of inflammatory bowel disease with urinary metabolic profiling Am. J. Gastroenterol. 2009, 104 (6) 1435-1444
16. Marchesi, J. R.; Holmes, E.; Khan, F.; Kochhar, S.; Scanlan, P.; Shanahan, F.; Wilson, I. D.; Wang, Y. L. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease J. Proteome Res. 2007, 6 (2) 546-551
17. Bjerrum, J. T.; Nielsen, O. H.; Hao, F. H.; Tang, H. R.; Nicholson, J. K.; Wang, Y. L.; Olsen, J. Metabonomics in ulcerative colitis: diagnostics, biomarker identification, and insight into the pathophysiology J. Proteome Res. 2010, 9 (2) 954-962
18. Gaudio, E.; Taddei, G.; Vetuschi, A.; Sferra, R.; Frieri, G.; Ricciardi, G.; Caprilli, R. Dextran sulfate sodium (DSS) colitis in rats: clinical, structural, and ultrastructural aspects Dig. Dis. Sci. 1999, 44 (7) 1458-1475
19. 1H NMR spectroscopy J. Proteome Res. 2010, 9 (12) 6265-6273
20. Xiao, C. N.; Hao, F. H.; Qin, X. R.; Wang, Y. L.; Tang, H. R. An optimized buffer system for NMR-based urinary metabonomics with effective pH control, chemical shift consistency and dilution minimization Analyst 2009, 134 (5) 916-925
21. Aue, W. P.; Bartholdi, E.; Ernst, R. R. Two dimensional spectroscopy. Application to nuclear magnetic resonance J. Chem. Phys. 1976, 64 (5) 2229-2246
22. 1H NMR metabonomics Anal. Chem. 2006, 78 (13) 4281-4290
23. Wold, S.; Esbensen, K.; Geladi, P. Principal component analysis Chemom. Intell. Lab. Syst. 1987, 2 (1-3) 37-52
24. Keun, H. C.; Ebbels, T. M. D.; Bollard, M. E.; Beckonert, O.; Antti, H.; Holmes, E.; Lindon, J. C.; Nicholson, J. K. Geometric trajectory analysis of metabolic responses to toxicity can define treatment specific profiles Chem. Res. Toxicol. 2004, 17 (5) 579-587
25. Trygg, J.; Wold, S. Orthogonal projections to latent structures (O-PLS) J. Chemom. 2002, 16 (3) 119-128
26. Trygg, J. O2-PLS for qualitative and quantitative analysis in multivariate calibration J. Chemom. 2002, 16 (6) 283-293
27. Lindgren, F.; Hansen, B.; Karcher, W.; Sjostrom, M.; Eriksson, L. Model validation by permutation tests: applications to variable selection J. Chemom. 1996, 10 (5-6) 521-532
28. Eriksson, L.; Trygg, J.; Wold, S. CV-ANOVA for significance testing of PLS and OPLS (R) models J. Chemom. 2008, 22 (11-12) 594-600
29. 1H NMR spectroscopic metabonomic studies Anal. Chem. 2005, 77 (2) 517-526
30. 13C NMR spectroscopy of human blood plasma Anal. Chem. 1995, 67 (5) 793-811
31. Wishart, D. S.; Tzur, D.; Knox, C.; Eisner, R.; Guo, A. C.; Young, N.; Cheng, D.; Jewell, K.; Arndt, D.; Sawhney, S.; Fung, C.; Nikolai, L.; Lewis, M.; Coutouly, M. A.; Forsythe, I.; Tang, P.; Shrivastava, S.; Jeroncic, K.; Stothard, P.; Amegbey, G.; Block, D.; Hau, D. D.; Wagner, J.; Miniaci, J.; Clements, M.; Gebremedhin, M.; Guo, N.; Zhang, Y.; Duggan, G. E.; MacInnis, G. D.; Weljie, A. M.; Dowlatabadi, R.; Bamforth, F.; Clive, D.; Greiner, R.; Li, L.; Marrie, T.; Sykes, B. D.; Vogel, H. J.; Querengesser, L. HMDB: the human metabolome database Nucleic Acids Res. 2007, 35, D521-D526
32. 1H NMR data sets Anal. Chem. 2005, 77 (5) 1282-1289
33. 4-induced systems alterations for multiple rat organs J. Proteome Res. 2012, 11 (7) 3848-3859
34. Martin, F. P. J.; Rezzi, S.; Montoliu, I.; Philippe, D.; Tornier, L.; Messlik, A.; Holzlwimmer, G.; Baur, P.; Quintanilla-Fend, L.; Loh, G.; Blaut, M.; Blum, S.; Kochhar, S.; Haller, D. Metabolic assessment of gradual development of moderate experimental colitis in IL-10 deficient mice J. Proteome Res. 2009, 8 (5) 2376-2387
35. Karlsson, A.; Jagervall, A.; Pettersson, M.; Andersson, A. K.; Gillberg, P. G.; Melgar, S. Dextran sulphate sodium induces acute colitis and alters hepatic function in hamsters Int. Immunopharmacol. 2008, 8 (1) 20-27
36. Warren, G. W.; Van Ess, P. J.; Watson, A. M.; Mattson, M. P.; Blouin, R. A. Cytochrome P450 and antioxidant activity in interleukin-6 knockout mice after induction of the acute-phase response J. Interferon Cytokine Res. 2001, 21 (10) 821-826
37. Yoshimoto, M.; Waki, A.; Yonekura, Y.; Sadato, N.; Murata, T.; Omata, N.; Takahashi, N.; Welch, M. J.; Fujibayashi, Y. Characterization of acetate metabolism in tumor cells in relation to cell proliferation: acetate metabolism in tumor cells Nucl. Med. Biol. 2001, 28 (2) 117-122
38. Hellerstein, M. K.; Schwarz, J. M.; Neese, R. A. Regulation of hepatic de novo lipogenesis in humans Annu. Rev. Nutr. 1996, 16, 523-557
39. Cheung, M. C.; Brown, B. G.; Larsen, E. K. M.; Frutkin, A. D.; O'Brien, K. D.; Albers, J. J. Phospholipid transfer protein activity is associated with inflammatory markers in patients with cardiovascular disease BBA-Mol. Basis Dis. 2006, 1762 (1) 131-137
40. Michel, V.; Yuan, Z. F.; Ramsubir, S.; Bakovic, M. Choline transport for phospholipid synthesis Exp. Biol. Med. 2006, 231 (5) 490-504
41. Perse, M.; Cerar, A. Dextran sodium sulphate colitis mouse model: traps and tricks J. Biomed. Biotechnol. 2012, 10.1155/2012/718617
42. Ni, J.; Chen, S. F.; Hollander, D. Effects of dextran sulphate sodium on intestinal epithelial cells and intestinal lymphocytes Gut 1996, 39 (2) 234-241
43. Araki, Y.; Mukaisyo, K. I.; Sugihara, H.; Fujiyama, Y.; Hattori, T. Increased apoptosis and decreased proliferation of colonic epithelium in dextran sulfate sodium-induced colitis in mice Oncol. Rep. 2010, 24 (4) 869-874
44. Grisham, M. B. Role of reactive oxygen metabolites in inflammatory bowel disease Curr. Opin. Gastroenterol. 1993, 9 (6) 971-980
45. Holmes, E. W.; Yong, S. L.; Eiznhamer, D.; Keshavarzian, A. Glutathione content of colonic mucosa: evidence for oxidative damage in active ulcerative colitis Dig. Dis. Sci. 1998, 43 (5) 1088-1095
46. Finkelstein, J. D. The metabolism of homocysteine: pathways and regulation Eur. J. Pediatr. 1998, 157, S40-S44
47. De la Fuente, M.; Hernanz, A.; Viniegra, S.; Miquel, J. Sulfur-containing antioxidants increase in vitro several functions of lymphocytes from mice Int. Immunopharmacol. 2011, 11 (6) 661-669
48. Larrosa, M.; Yanez-Gascon, M. J.; Selma, M. V.; Gonzalez-Sarrias, A.; Toti, S.; Ceron, J. J.; Tomas-Barberan, F.; Dolara, P.; Espin, J. C. Effect of a low dose of dietary resveratrol on colon microbiota, inflammation and tissue damage in a DSS-induced colitis rat model J. Agric. Food Chem. 2009, 57 (6) 2211-2220
49. Harris, R. R.; Carter, G. W.; Bell, R. L.; Moore, J. L.; Brooks, D. W. Clinical activity of leukotriene inhibitors Int. J. Immunopharmacol. 1995, 17 (2) 147-156
50. Heller, A.; Koch, T.; Schmeck, J.; van Ackern, K. Lipid mediators in inflammatory disorders Drugs 1998, 55 (4) 487-496
51. Dong, F.; Wang, B.; Zhang, L.; Tang, H.; Li, J.; Wang, Y. Metabolic response to klebsiella pneumoniae infection in an experimental rat model PLoS ONE 2012, 7 (11) e51060
52. Yan, Y. T.; Kolachala, V.; Dalmasso, G.; Nguyen, H.; Laroui, H.; Sitaraman, S. V.; Merlin, D. Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis PLoS ONE 2009, 4 (6) e6073
53. Tlaskalova-Hogenova, H.; Stepankova, R.; Hudcovic, T.; Tuckova, L.; Cukrowska, B.; Lodinova-Zadnikova, R.; Kozakova, H.; Rossmann, P.; Bartova, J.; Sokol, D.; Funda, D. P.; Borovska, D.; Rehakova, Z.; Sinkora, J.; Hofman, J.; Drastich, P.; Kokesova, A. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases Immunol. Lett. 2004, 93 (2-3) 97-108
54. Hans, W.; Scholmerich, J.; Gross, V.; Falk, W. The role of the resident intestinal flora in acute and chronic dextran sulfate sodium-induced colitis in mice Eur. J. Gastroenterol. Hepatol. 2000, 12 (3) 267-273
55. Okayasu, I.; Hatakeyama, S.; Yamada, M.; Ohkusa, T.; Inagaki, Y.; Nakaya, R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice Gastroenterology 1990, 98 (3) 694-702
56. Smith, E. A.; Macfarlane, G. T. Enumeration of human colonic bacteria producing phenolic and indolic compounds: effects of pH, carbohydrate availability and retention time on dissimilatory aromatic amino acid metabolism J. Appl. Bacteriol. 1996, 81 (3) 288-302
57. Donaldson, R. M. Excretion of tryptamine and indole-3-acetic acid in urine of rats with intestinal diverticula Am. J. Physiol. 1962, 202 (2) 289-292